► Sharekhan (Free Demat)

Metropolis Healthcare IPO Dates, Review, Price Band, Market Lot Details

Table of Contents

Metropolis Healthcare ipo to hit the market on 03-April-2019. Metropolis Healthcare is a leading diagnostics companies in India as per revenue. They have their presence in 18 states while leadership position in west and south India. They offer comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease. They already made 16.0 million tests from approximately 7.7 million patient visits.

Metropolis Healthcare IPO Review:

  • Apply with Long Term View

Metropolis Healthcare IPO Dates & Price Band:

  • IPO Open: 03-April-2019
  • IPO Close: 05-April-2019
  • IPO Size: Approx ₹1204 Crore
  • Face Value: ₹2 Per Equity Share
  • Price Band: ₹877 to ₹880 Per Share
  • Listing on: BSE & NSE
  • Retail Portion: 10%
  • QIB Portion: 75%
  • HNI Portion: 15%
  • Equity: 15,269,684 Shares

Metropolis Healthcare IPO Market Lot:

  • Shares: Apply for 17 Shares (Minimum Lot Size)
  • Amount: ₹14,960

    Metropolis Healthcare IPO Allotment & Listing:

    • Basis of Allotment: 10-April-2019
    • Refunds: 11-April-2019
    • Credit to demat accounts: 12-April-2019
    • Listing: 15-April-2019

      Read Also
      IPO Grey Market Premium
      IPO Subscription Numbers
      IPO Listing Date

      Metropolis Healthcare Financial:

        ₹ in Crore

      Company Promoters:

      • Dr. Shushil Kanubhai Shah
      • Ameera Shushil Shah
      • Metaz Advisory LLP

      Quick Links:
      DRHP Draft Prospectus
      RHP Draft Prospectus

      Initial public offering of up to 15,269,684 equity shares of face value of Rs. 2 each (the equity shares) of the company for cash at a price of Rs. (*) per equity share aggregating up to Rs. (*) Crores, consisting of an offer for sale of up to 5,017,868 equity shares by Dr. Sushil Kanubhai Shah (the promoter selling shareholder) aggregating up to (*) Crores and up to 10,251,816 equity shares by Ca Lotus Investments (the investor selling shareholder) aggregating up to (*) Crores (the offer). The offer includes a reservation of up to 300,000 equity shares aggregating up to Rs. (*) Crores, for subscription by eligible employees (as defined hereinafter) (the employee reservation portion). The offer less the employee reservation portion is hereinafter referred to as the net offer and such net offer aggregates up to 14,969,684 equity shares. The offer and the net offer shall constitute (*)% and (*)%, respectively, of the Post-offer paid-up equity share capital of the company.The face value of equity shares is Rs. 2 each. The price band and the minimum bid lot will be decided by the company.

      Metropolis Healthcare IPO Registrar:
      Link Intime India Private Limited
      C-101, 1st floor, 247 Park
      L B S Marg, Vikhroli West
      Mumbai 400 083
      Tel: (91 22) 4918 6200
      Facsimile: (91 22) 4918 6195
      E-mail: [email protected]
      Investor grievance e-mail: [email protected]
      Website: www.linkintime.co.in
      Note: Check Metropolis Healthcare ipo allotment status on Linkintime website allotment url. Click Here

      Metropolis Healthcare IPO Lead Managers:

      • JM Financial Limited
      • Credit Suisse Securities (India)
      • Private Limited
      • Goldman Sachs (India)
      • Securities Private Limited
      • HDFC Bank Limited 
      • Kotak Mahindra Capital
      • Company Limited

      Company Address:
      Metropolis Healthcare Limited
      250 D Udyog Bhavan,
      Hind Cycle Marg, Worli,
      Mumbai 400 030,
      Tel: (91 22) 6258 2810
      Contact Person: Jayant Prakash
      Head Legal, Company Secretary and Compliance Officer
      E-mail: [email protected]
      Website: www.metropolisindia.com

      Note: The ipo price band and dates will be added as it will be officially announced. The ipo grey market premium (ipo gmp) will be added on the grey market page as it will start)

      Share the Post:

      0 Responses

      Leave a Reply

      Your email address will not be published. Required fields are marked *